FreeOx acquires the patent for the drug Ox-01 in the US for ischaemic stroke

por CataloniaBio

FreeOx Biotech, a CataloniaBio & HealthTech member, has been granted a patent for its most advanced drug, Ox-01, by the United States Patent and Trademark Office (USPTO). The patent protects the use o...

Leer más

When Standardization Meets Customization

por Pall Biotech

To bring your biologic to market as quickly as possible, streamlined scale up is essential. By combining standardized, single-use platform technologies that can be customized to your particular proces...

Leer más

VHIR obtains more than €1 million from the use of a patent

por CataloniaBio

The Vall d’Hebron​ Research Institute (VHIR) obtained more than €1 million in profit from the use of a patent of a new treatment for a mitochondrial rare disease caused by TK2 deficiency. It is ...

Leer más
Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Destacadas

Entrevista con Dámaso Molero, director ...

by 3P Biopharmaceuticals

Dámaso Molero:" Creo que en Latinoamérica habrá negocio en el d...

Cada vez más cerca de inhibir el gen My...

by VHIO

Hemos recorrido un largo camino hasta llegar a este punto, con multitu...

Diapositiva de Fotos